Cargando…
Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
Candida species are the most common fungal pathogens to infect humans, and can cause life-threatening illnesses in individuals with compromised immune systems. Fluconazole (FLU) is the most frequently administered antifungal drug, but its therapeutic efficacy has been limited by the emergence of dru...
Autores principales: | Tan, Jingwen, Jiang, Shaojie, Tan, Lihua, Shi, Haiyan, Yang, Lianjuan, Sun, Yi, Wang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155715/ https://www.ncbi.nlm.nih.gov/pubmed/34054751 http://dx.doi.org/10.3389/fmicb.2021.649026 |
Ejemplares similares
-
Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata
isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017) -
A Preliminary in vitro and in vivo Evaluation of the Effect and Action Mechanism of 17-AAG Combined With Azoles Against Azole-Resistant Candida spp.
por: Liu, Luyao, et al.
Publicado: (2022) -
In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species
por: Jiang, Huiping, et al.
Publicado: (2022) -
P029 Synergic effect of deferoxamine combined with fluconazole against fluconazole-resistant Candida Spp. through inhibited Cek1 MAPK signaling pathway
por: An, Lulu, et al.
Publicado: (2022)